SCHEMBL560144

SCHEMBL560144

O=C(Nc1nccc2cccnc12)c1cccc2cnc(N[C@H]3CC[C@H](O)CC3)nc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 6/20 0.50
JUN P05412 2/20 0.50
MAPK8 P45983 9/20 0.43
MAPK9 P45984 7/20 0.43
SYK P43405 1/20 0.42
IRAK1 P51617 1/20 0.42
IRAK4 Q9NWZ3 1/20 0.42
AXL P30530 3/20 0.41
TYRO3 Q06418 3/20 0.41
MERTK Q12866 3/20 0.41
FLT3 P36888 1/20 0.41
GAS6 Q14393 1/20 0.41
NPC1 O15118 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2259620 0.83 MAPK10 (0.50) MAPK10JUNMAPK8MAPK9SYK
SCHEMBL558797 0.83 MAPK10 (0.50) MAPK10JUNMAPK8MAPK9SYK
SCHEMBL2261729 0.82 MAPK10 (0.52) MAPK10JUNMAPK8MAPK9SYK
SCHEMBL2260794 0.82 MAPK10 (0.49) MAPK10JUNMAPK8MAPK9SYK
SCHEMBL559091 0.82 MAPK10 (0.49) MAPK10JUNMAPK8MAPK9SYK
SCHEMBL559698 0.82 MAPK10 (0.52) MAPK10JUNMAPK8MAPK9SYK
SCHEMBL2257466 0.82 MAPK10 (0.51) MAPK10JUNMAPK8MAPK9SYK
SCHEMBL558493 0.82 MAPK10 (0.51) MAPK10JUNMAPK8MAPK9SYK
SCHEMBL2256528 0.81 MAPK10 (0.56) MAPK10JUNMAPK8MAPK9AXL
SCHEMBL2256524 0.81 MAPK10 (0.56) MAPK10JUNMAPK8MAPK9AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120035194-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER INC. (US) 2012-02-09 US disclosed
US-20120035194-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER INC. (US) 2012-02-09 US disclosed
US-20120035194-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER INC. (US) 2012-02-09 US disclosed
US-7998978-B2 Substituted 2-amino-fused heterocyclic compounds PFIZER INC. (US) 2011-08-16 US disclosed
US-7998978-B2 Substituted 2-amino-fused heterocyclic compounds PFIZER INC. (US) 2011-08-16 US disclosed
US-7998978-B2 Substituted 2-amino-fused heterocyclic compounds PFIZER INC. (US) 2011-08-16 US disclosed
US-20100056506-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER PRODUCTS INC. (US) 2010-03-04 US disclosed
US-20100056506-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER PRODUCTS INC. (US) 2010-03-04 US disclosed
US-20100056506-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS PFIZER PRODUCTS INC. (US) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035194-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS MAPK1, SLC5A1, ATF1 MAPK10 32/4885JUN 36/4885MAPK8 20/4885
US-20100056506-A1 SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS MAPK1, SLC5A1, ATF1 MAPK10 32/4885JUN 36/4885MAPK8 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.